SEC Form 4/A · accession 0001209191-15-034074
Foundation Medicine, Inc. · FMI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Robert W. Hesslein
Officer — SVP and General Counsel
Period of report
Apr 7, 2015
Accepted (ET)
Apr 14, 2015 · 6:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001488613
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 7, 2015 | U | 35,900 | $50.00 | D | 32,225 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This amended Form 4 represents the final number of shares sold by the reporting person in connection with the tender offer for shares of Common Stock of the Issuer (the "Tender Offer") by Roche Holdings, Inc. The final proration factor for the Tender Offer is 83.2%.